Loading…
Loading…
Edwards Lifesciences Corp
NYSE · Stock Profile · Market Cap $47.91B
Current Price
$82.61
-1.97%GoodMoat Value
$52.73
36.2% overvaluedTrading 36% above its estimated fair value of $52.73.
Forward estimates use 29.3% FCF growth (CAGR)
Net Cash: 2.2B
1.4B
FY24
1.4B
FY24
5.4B
FY24
1.4B
FY25
1.5B
FY25
1.6B
FY25
6.1B
FY25
366M
FY24
3.1B
FY24
4.2B
FY24
358M
FY25
333M
FY25
291M
FY25
1.1B
FY25
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Country
California, USA
Earnings per share grew at a 29.3% CAGR.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Country
California, USA